
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
NTLA | NASDAQ | USD | Real-time | |
0JBU | London | USD | Real-time | |
38I | TradeGate | EUR | Delayed | |
38I | Frankfurt | EUR | Delayed |
Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Franciscus A. G. M. Verwiel | 59 | 2017 | Independent Chairman of the Board |
John M. Leonard | 64 | 2014 | President, CEO & Director |
William J. Chase | 55 | 2023 | Independent Director |
Arthur M. Krieg | 68 | - | Member of Scientific Advisory Board |
Jesse L. Goodman | 74 | 2018 | Independent Director |
Beverly L. Davidson | - | 2015 | Member of Scientific Advisory Board |
Fred E. Cohen | 69 | 2019 | Independent Director |
Muna Bhanji | 62 | 2022 | Independent Director |
Georgia Keresty | 63 | 2021 | Independent Director |
Brian M. Goff | 56 | 2024 | Independent Director |
Nessan Bermingham | 52 | 2014 | Founder & Member of Scientific Advisor Board |
Jennifer A. Doudna | 60 | 2015 | Founder & Member of Scientific Advisor Board |
Andrew May | - | - | Founder and Member of Scientific Advisor Board |
Luciano Marraffini | - | - | Founder & Member of Scientific Advisor Board |
Derrick J. Rossi | - | 2015 | Founder & Member of Scientific Advisor Board |
Erik J. Sontheimer | - | - | Founder & Member of Scientific Advisor Board |
Rodolphe Barrangou | - | - | Founder & Member of Scientific Advisor Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review